GATEWAY Sciences sponsors and engages in research into psilocybin, the future of psychedelic medicine, and psychedelic microdosing. By working with the best institutions and professors from around the globe, GATEWAY Sciences is focusing on research into psilocybin’s role in combatting anxiety, depression, and PTSD. GATEWAY Sciences is at the forefront of this new emerging mental health movement.
GATEWAY Sciences consumer packaged goods focus on today’s mushroom medicine. Featuring innovative high-quality delivery methods of Lion’s Mane, Chaga, Cordyceps, Reishi, Shiitake, and working with the best Nordic mushroom growers, GATEWAY Sciences offers mushrooms as medicine to consumers around the world.
GATEWAY Sciences has been involved in nutritional mycology research with European-based academic universities. Fungi is the future of plant-based protein sources due to its sustainable farming, full amino proteins, and naturally occurring vitamins and minerals. Our goal is to make these solutions scalable for a future alternative to meat consumption.